Ameriprise’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$190M Sell
1,610,634
-326,297
-17% -$40.3M 0.04% 381
2025
Q4
$244M Sell
1,936,931
-1,355,905
-41% -$177M 0.06% 321
2025
Q3
$486M Buy
3,292,836
+93,343
+3% +$14.1M 0.11% 193
2025
Q2
$498M Sell
3,199,493
-177,691
-5% -$28.2M 0.12% 175
2025
Q1
$557M Buy
3,377,184
+161,431
+5% +$26.8M 0.15% 150
2024
Q4
$524M Buy
3,215,753
+159,382
+5% +$28.5M 0.13% 165
2024
Q3
$597M Sell
3,056,371
-43,012
-1% -$7.93M 0.15% 147
2024
Q2
$537M Sell
3,099,383
-1,124,220
-27% -$187M 0.15% 154
2024
Q1
$712M Buy
4,223,603
+1,247,513
+42% +$234M 0.2% 106
2023
Q4
$587M Sell
2,976,090
-115,027
-4% -$20.4M 0.18% 125
2023
Q3
$538M Sell
3,091,117
-147,991
-5% -$26.9M 0.18% 122
2023
Q2
$558M Buy
3,239,108
+398,969
+14% +$69M 0.17% 122
2023
Q1
$473M Buy
2,840,139
+1,001,268
+54% +$164M 0.16% 150
2022
Q4
$270M Buy
1,838,871
+338,724
+23% +$50.1M 0.09% 232
2022
Q3
$223M Buy
1,500,147
+389,806
+35% +$65.1M 0.08% 252
2022
Q2
$190M Buy
1,110,341
+169,336
+18% +$29.3M 0.07% 302
2022
Q1
$175M Sell
941,005
-838,067
-47% -$166M 0.05% 371
2021
Q4
$430M Buy
1,779,072
+60,223
+4% +$13.2M 0.12% 180
2021
Q3
$334M Buy
1,718,849
+828,340
+93% +$167M 0.11% 206
2021
Q2
$166M Buy
890,509
+156,883
+21% +$27.2M 0.05% 372
2021
Q1
$116M Buy
733,626
+131,791
+22% +$20.9M 0.04% 454
2020
Q4
$99.6M Sell
601,835
-102,379
-15% -$16.6M 0.04% 473
2020
Q3
$117M Sell
704,214
-150,548
-18% -$23.1M 0.05% 382
2020
Q2
$117M Buy
854,762
+75,223
+10% +$9.82M 0.05% 355
2020
Q1
$91.8M Sell
779,539
-107,346
-12% -$14.1M 0.05% 354
2019
Q4
$117M Sell
886,885
-32,290
-4% -$4.01M 0.05% 359
2019
Q3
$114M Sell
919,175
-143,222
-13% -$17.3M 0.05% 354
2019
Q2
$121M Buy
1,062,397
+43,524
+4% +$4.56M 0.05% 351
2019
Q1
$103M Sell
1,018,873
-65,802
-6% -$5.97M 0.05% 402
2018
Q4
$92.8M Sell
1,084,675
-201,397
-16% -$18.1M 0.05% 397
2018
Q3
$118M Sell
1,286,072
-116,235
-8% -$10.3M 0.04% 402
2018
Q2
$119M Buy
1,402,307
+5,115
+0.4% +$432K 0.05% 355
2018
Q1
$117M Sell
1,397,192
-236,662
-14% -$18.6M 0.05% 340
2017
Q4
$118M Buy
1,633,854
+415,726
+34% +$28.6M 0.05% 340
2017
Q3
$77.7M Sell
1,218,128
-281,796
-19% -$17.7M 0.04% 432
2017
Q2
$93.6M Sell
1,499,924
-114,492
-7% -$6.76M 0.05% 372
2017
Q1
$86.2M Buy
1,614,416
+281,139
+21% +$15.2M 0.04% 382
2016
Q4
$71.4M Sell
1,333,277
-525,890
-28% -$26.7M 0.04% 424
2016
Q3
$96.7M Sell
1,859,167
-50,196
-3% -$2.54M 0.05% 343
2016
Q2
$90.6M Buy
1,909,363
+564,403
+42% +$26.7M 0.05% 328
2016
Q1
$59M Buy
1,344,960
+266,678
+25% +$11.3M 0.04% 428
2015
Q4
$51.7M Sell
1,078,282
-507,056
-32% -$22.9M 0.03% 463
2015
Q3
$65.3M Buy
1,585,338
+160,934
+11% +$7.46M 0.04% 391
2015
Q2
$68.7M Buy
1,424,404
+809,376
+132% +$38.6M 0.04% 415
2015
Q1
$28.5M Buy
615,028
+40,393
+7% +$1.82M 0.02% 789
2014
Q4
$24.7M Sell
574,635
-2,872,077
-83% -$117M 0.01% 838
2014
Q3
$127M Buy
3,446,712
+18,702
+0.5% +$640K 0.08% 271
2014
Q2
$111M Buy
3,428,010
+2,590,262
+309% +$79.5M 0.07% 283
2014
Q1
$24.2M Sell
837,748
-1,442,195
-63% -$44M 0.01% 879
2013
Q4
$74.5M Buy
2,279,943
+576,543
+34% +$18.4M 0.05% 390
2013
Q3
$53M Buy
1,703,400
+860,059
+102% +$26.3M 0.03% 505
2013
Q2
$26.1M Buy
+843,341
New +$27.3M 0.02% 834

Other funds holding ZTS

Ameriprise's ZTS Position: Q1 2026 in Review

Ameriprise reduced its Zoetis (ZTS) stake by 17% in Q1 2026, selling an estimated $40.3M and leaving 1,610,634 shares worth $190M. The position accounts for 0.04% of the portfolio, ranked #381.

Ameriprise first reported a position in ZTS in Q2 2013 and has held it in 52 quarters since. The position peaked at $712M in Q1 2024. 1,604 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Ameriprise held 1,610,634 shares of Zoetis worth $190M as of Q1 2026.
  • Ameriprise sold 326,297 Zoetis shares in Q1 2026, an estimated $40.3M.
  • Zoetis made up 0.04% of Ameriprise's portfolio in Q1 2026, its #381 holding.
  • Ameriprise first reported a position in Zoetis in Q2 2013 and has held it in 52 quarters since.
  • Ameriprise's Zoetis position peaked at $712M in Q1 2024.
  • 1,604 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.